NCT01665274 Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer Status TERMINATED Phase PHASE2
NCT01662869 A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer Status COMPLETED Phase PHASE3
NCT01660711 A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT01658943 Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT01652196 Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01650428 Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery Status COMPLETED Phase PHASE2
NCT01643499 Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies Status COMPLETED Phase PHASE1
NCT01633970 A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01630083 Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer Status COMPLETED Phase PHASE2
NCT01590719 A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer Status COMPLETED Phase PHASE2
NCT01588990 A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE4
NCT01580410 Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix Status COMPLETED Phase PHASE2
NCT01566942 FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT01561014 Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Status COMPLETED Phase PHASE1
NCT01560949 Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE2
NCT01558869 Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT01554059 Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients Status COMPLETED Phase PHASE2
NCT01542294 SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer Status UNKNOWN Phase PHASE1/PHASE2